De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study
- Resource Type
- Article
- Source
- In
Annals of Oncology June 2019 30(6):921-926 - Subject
- Language
- ISSN
- 0923-7534